Sage Therapeutics Inc call shares owned by Simplex Trading
Quarter-by-quarter ownership of Sage Therapeutics Inc call shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Sage Therapeutics Inc call
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics Inc call held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics Inc call by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.2M | 160k | 7.22 |
| 2024-06-30 | $1.0M | 94k | 10.86 |
| 2024-03-31 | $1.1M | 59k | 18.72 |
| 2023-12-31 | $1.4M | 65k | 21.66 |
| 2023-09-30 | $2.6M | 128k | 20.58 |
| 2023-06-30 | $343k | 7.3k | 46.99 |
| 2023-03-31 | $276k | 6.6k | 41.82 |
| 2022-12-31 | $1.0M | 27k | 38.11 |
| 2022-09-30 | $1.2M | 32k | 39.15 |
| 2022-06-30 | $497k | 15k | 32.27 |
| 2022-03-31 | $95k | 2.9k | 32.76 |
| 2021-12-31 | $935k | 16k | 57.36 |
| 2021-09-30 | $935k | 16k | 57.36 |
| 2021-06-30 | $931k | 16k | 56.77 |
| 2021-03-31 | $299 | 40 | 7.48 |
| 2020-12-31 | $2.4k | 275 | 8.65 |
| 2020-09-30 | $2.8k | 462 | 6.11 |
| 2020-06-30 | $1.2k | 298 | 4.16 |
| 2020-03-31 | $628 | 219 | 2.87 |
| 2019-12-31 | $6.8k | 949 | 7.22 |
| 2019-09-30 | $2.0k | 143 | 14.03 |
| 2019-06-30 | $3.1k | 170 | 18.31 |
| 2019-03-31 | $4.2k | 266 | 15.90 |
| 2018-12-31 | $1.6k | 166 | 9.58 |
| 2018-09-30 | $1.3k | 93 | 14.12 |
| 2018-06-30 | $1.3k | 84 | 15.64 |
| 2018-03-31 | $122k | 79 | 1544.30 |
| 2017-12-31 | $1.5M | 279 | 5516.13 |
| 2017-09-30 | $93k | 154 | 603.90 |
| 2017-06-30 | $169k | 193 | 875.65 |
| 2017-03-31 | $193k | 406 | 475.37 |
| 2016-12-31 | $123k | 144 | 854.17 |
| 2016-09-30 | $63k | 194 | 324.74 |
| 2016-06-30 | $8.0k | 38 | 210.53 |
| 2016-03-31 | $3.0k | 10 | 300.00 |
| 2015-09-30 | $1.0k | 7 | 142.86 |
| 2015-06-30 | $13k | 22 | 590.91 |
Top funds holding Sage Therapeutics Inc call
View all funds holding Sage Therapeutics Inc call